Post COVID-19 syndrome and new onset diseases: a prospective observational study.
10.4103/singaporemedj.SMJ-2022-055
- Author:
Nitin SINHA
1
;
Mahinder Pal Singh CHAWLA
1
;
Desh DEEPAK
2
;
Amit SURI
2
;
Piyush JAIN
1
;
Ankit AGARWAL
1
;
Manoj Kumar BHAKHAR
1
Author Information
1. Department of Medicine, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India.
2. Department of Respiratory Medicine, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, New Delhi, India.
- Publication Type:Observational Study
- Keywords:
New-onset diseases post-COVID-19;
ongoing symptomatic COVID-19;
post-COVID-19 sequelae;
post-COVID-19 syndrome;
predictors of post-COVID-19 syndrome
- MeSH:
Humans;
COVID-19/diagnosis*;
Female;
Male;
Prospective Studies;
Middle Aged;
Adult;
Fatigue/etiology*;
Post-Acute COVID-19 Syndrome;
SARS-CoV-2;
Aged;
Cough/etiology*;
Dyspnea/etiology*
- From:Singapore medical journal
2025;66(7):354-361
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTION:The National Institute of Health and Care Excellence (NICE) has defined the terms, 'acute coronavirus disease 2019' (COVID-19), 'ongoing symptomatic COVID-19' and 'post-COVID-19 syndrome', with the latter two described as having persistent symptoms after the onset of COVID-19 symptoms for 4-12 weeks and >12 weeks, respectively. Persistent symptoms can either be due to the after-effects of COVID-19 or new-onset diseases after acute COVID-19. All symptoms observed beyond 4 weeks after the onset of COVID-19 need not be present at the time of onset. Previous studies on persistent post-COVID-19 symptoms have not mentioned new-onset diseases after acute COVID-19, and only a select few studies have discussed such new-onset symptoms.
METHODS:Ninety-five patients who attended the post-COVID-19 clinic completed the requisite follow-up till 16 weeks after COVID-19 symptom onset. Data was recorded on a predesigned proforma. Necessary investigations were conducted to rule out any other cause of persistent symptoms.
RESULTS:Fatigue (62.1%), breathlessness (50.5%) and cough (27.4%) were the most common symptoms present beyond 4 weeks after the onset of COVID-19 symptoms. Forty-nine (51.57%) patients developed post-COVID-19 syndrome - their severity of symptoms (odds ratio [OR] 17.77) and longer duration of hospital stay (OR 1.095) during acute disease were significantly associated with the development of post-COVID-19 syndrome. During follow-up, 25 patients developed new-onset symptoms, such as diabetes mellitus, hypertension and idiopathic tachycardia.
CONCLUSION:Patients can have persistent symptoms, new-onset symptoms and new-onset diseases after recovery from acute COVID-19.
